Navigation Links
Cempra to Present Data on Solithromycin's (CEM-101) Potential Against Urogenital Infections and Multidrug-Resistant Pathogens at ECCMID
Date:4/26/2013

CHAPEL HILL, N.C., April 26, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infections, today announced that it will present data at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Berlin, demonstrating solithromycin's potential to treat urogenital infections and combat challenging pathogens such as enterococci and Legionella pneumophila. All of the presentations will occur on Sunday, April 28.

"Solithromycin, our fourth-generation macrolide, has the right spectrum of activity against a variety of serious gram positive pathogens as well as an emerging favorable safety profile," said Prabha Fernandes , Ph.D., chief executive officer of Cempra.  "The studies to be presented at ECCMID demonstrate the antibiotic's potential against bacterial urethritis as well as against serious pathogens such as enterococcus and Legionella for which therapeutic options are either few or decreasing due to increasing antibiotic resistance.  Solithromycin continues to differentiate itself against other treatments for community-acquired bacterial pneumonia, sexually-transmitted diseases and other serious infections."

Abstract O 274: 11:42-11:54 a.m. CEST: A phase II study to evaluate the efficacy and safety of single-dose oral solithromycin (CEM-101) for treatment of patients with uncomplicated urogenital gonorrhea

E. Hook, III, D. Oldach, B. Jamieson, K. Clark, P. Fernandes

  • Patients with suspected N. gonorrhoeae infections received a single oral 1,200 mg dose of solithromycin
  • Infections were eradicated from all 22 evaluable patients
    '/>"/>

SOURCE Cempra, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cempra, Inc. to Report First Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on May 10, 2012
2. Cempra, Inc. to Present at the Global Technology Community 9th Anti-Infectives Partnering and Deal-Making Conference
3. Cempra, Inc. to Report Second Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on August 8, 2012
4. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
5. Cempra, Inc. Reports Second Quarter 2012 Financial and Operating Results
6. Cempra, Inc., to Present at 2012 Stifel Nicolaus Healthcare Conference and NewsMakers in the Biotech Industry Conference
7. Cempra, Inc. to Report Third Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on November 8, 2012
8. Cempra, Inc. to Present at the Jefferies 2012 Global Healthcare Conference in London
9. Cempra, Inc. to Present at Oppenheimer 23rd Annual Healthcare Conference
10. Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempras Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model
11. Cempra, Inc. to Report Fourth Quarter and Full Year 2012 Financial and Operating Results, and Host Conference Call and Webcast on February 28, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ ... into non-exclusive Development Agreements with Dexcom, Inc. to ... pumps with the Dexcom G5 and G6 continuous ... next generation pump platform with Dexcom,s future CGM ...
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... SOUTH PLAINFIELD, N.J., July 30, 2015 PTC ... corporate update and reported financial results for the second ... is progressing on many fronts across the organization.  We ... largest Duchenne muscular dystrophy clinical trial ever conducted with ... W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10
... factors such as high blood sugar and insulin, and ... pregnancy, predict whether a woman will develop diabetes during ... in the current issue of the American Journal ... suggests that metabolic screening of all women before pregnancy, ...
... Cardiogenesis Corporation (OTCQB: CGCP), a leading developer ... diffuse coronary artery disease, reported the enrollment of ... Study.  Dr. Guillermo Reyes at La Princesa Hospital, ... proprietary PHOENIX System that combines the intramyocardial delivery ...
Cached Medicine Technology:Metabolic Status Before Pregnancy Predicts Subsequent Gestational Diabetes 2Metabolic Status Before Pregnancy Predicts Subsequent Gestational Diabetes 3Metabolic Status Before Pregnancy Predicts Subsequent Gestational Diabetes 4Metabolic Status Before Pregnancy Predicts Subsequent Gestational Diabetes 5Cardiogenesis Enrolls First Two Patients in Its Feasibility Study of the PHOENIX® Combination Delivery System 2Cardiogenesis Enrolls First Two Patients in Its Feasibility Study of the PHOENIX® Combination Delivery System 3
(Date:8/1/2015)... CA (PRWEB) , ... August 01, 2015 , ... Have you ever wondered what “Karma” ... when you hear the word “Karma.” , Vedic tradition, which gave birth to Hinduism, ... is one of the central concepts of this tradition. According to the wisdom of this ...
(Date:8/1/2015)... ... August 01, 2015 , ... Professional Orthopedic ... company has acquired Premier Physical Therapy & Wellness (“Premier”) — with 13 locations ... clinics. , “Our acquisition of Premier Physical Therapy & Wellness solidifies Professional as ...
(Date:8/1/2015)... ... ... 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for Addiction Recovery (CCAR) ... Springer Mountain and heading north. Since that day, Phil has hiked over 1400 miles in ... friends and family. He visited CCAR and left an inspirational message to his staff: ...
(Date:7/31/2015)... ... ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on Sunday, ... Bowl. In the two weeks that separate the conference championships and the Super Bowl, there ... game will mark the 50th time it has been held and the festivities will take ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to Fight On ... on October 3, 2015. The Ride to Fight On is a cycling fundraiser that ... Healthcare, The West Clinic and The University of Tennessee Health Science Center. A health ...
Breaking Medicine News(10 mins):Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
... Thoratec Corporation,(Nasdaq: THOR ), a world leader ... restore failing hearts, today said that,revenues for fiscal 2008 ... For the year ended January ... revenues of $234.8 million in fiscal 2007. Revenues for,the ...
... Positive Operating Cash Flow in Fourth QuarterSAN DIEGO, Feb. 5 ... BioZ(R) Impedance Cardiography (ICG) technology, today reported financial results for its ... Results for Fourth Quarter 2008 Compared with Fourth Quarter 2007 , ... Net ICG sales increased 6% to $6.5 million, up from $6.2 ...
... can affect learning in children , , THURSDAY, Feb. 5 ... may affect their children,s memory and the severity of ... brain function of pre-adolescent mice with a genetically engineered ... the mice were given two weeks of exposure to ...
... problems, study finds , , THURSDAY, Feb. 5 (HealthDay News) -- ... toxic dust after the Sept. 11, 2001, terror attack in ... new study finds. , The rate of problems is much ... expected in people who smoke, said study co-author Dr. Jacqueline ...
... Calif., Feb. 5 Cepheid (Nasdaq: CPHD ) ... $37.8 million. Net loss was $5.9 million, or $(0.10) ... a net loss of $5.3 million, or $(0.10) per share, ... of purchased intangible assets and stock compensation expenses, non-GAAP net ...
... 5 Impersonating nurses in a,multimillion dollar campaign ... to a phony RN group, and the diversion ... Employees International Union has,sharply escalated an offensive to ... California Nurses Association/NNOC charged today. , ...
Cached Medicine News:Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 2Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 3Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 4Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 5Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 6Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 7Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 8Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 9Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 10Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 11Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 12Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 13Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 14Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 15Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 16Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 17Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 18Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 2Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 3Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 4Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 5Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 6Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 7Health News:What Moms Learned May Be Passed to Offspring 2Health News:Lung Problems Persist for 9/11 Responders 2Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 2Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 3Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 4Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 5Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 6Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 7Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 8Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 9Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 10Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 11
... specifically designed to work with the EC120 ... a small tank blotter that incorporates the ... buffer requirements and fast transfer rates), with ... blotting such as arcing and buffer depletion. ...
... The XCell II Blot Module allows you to ... to membranes. It fits neatly into the XCell ... the gel/buffer core assembly. It requires less than ... and northern transfers. Tough platinized titanium and stainless ...
... The GENIE is the proven electrophoretic transfer ... ultimate in field uniformity. Its design allows ... electrodes which, when coupled with a low ... charger, creates a high field in volts/cm. ...
Semi-Dry Blotting Unit for 10 x 10cm Gels...
Medicine Products: